Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of 2 doses of TAK-875 (25 mg and 50 mg), once daily (QD), plus metformin compared to placebo plus metformin and sitagliptin plus metformin on lowering blood sugar.


Clinical Trial Description

TAK-875 is being developed at Takeda Global Research and Development, Inc. as an adjunct to diet and exercise to improve glycemic control in participants with Type 2 Diabetes Mellitus (T2DM) whose blood glucose level is inadequately controlled with metformin.

This study will evaluate the efficacy of TAK-875 (25 mg and 50 mg) plus metformin compared to placebo plus metformin and sitagliptin plus metformin on glycemic control as measured by change from baseline in glycosylated hemoglobin (HbA1c) over a 24-week Treatment Period. Participants completing the 24-week Treatment Period may enter an optional 80-week extension period for a total of 104 weeks of treatment.

Due to potential concerns about liver safety, on balance, the benefits of treating patients with fasiglifam (TAK-875) do not outweigh the potential risks.

For this reason, Takeda has decided voluntarily to terminate the development activities for fasiglifam. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01549964
Study type Interventional
Source Takeda
Contact
Status Terminated
Phase Phase 3
Start date May 2012
Completion date May 2016

See also
  Status Clinical Trial Phase
Completed NCT06309654 - Home-Based Circuit Training in Overweight/Obese Older Adult Patients With Knee Osteoarthritis and Type 2 Diabetes N/A
Active, not recruiting NCT05460884 - Effects of Seaweed Extract on Postprandial Response to White Bread N/A
Completed NCT00576394 - Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients Phase 1
Recruiting NCT05777746 - The Effect of an Online Plant-Based Dietary Program on Cardiovascular Risk Factors in Persons With Type 2 Diabetes Mellitus: A Randomized Controlled Trial N/A
Completed NCT00898534 - Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus Phase 4
Recruiting NCT05115682 - Circadian Rhythm and Metabolic Effects of Exercise N/A
Completed NCT04994327 - Bread Replacement - Facing the Challenge to Improve Its Quality for Better Metabolic Health N/A
Recruiting NCT04332393 - Metformin to Treat Corticosteroids-induced Hyperglycemia Phase 4
Recruiting NCT04821752 - Environmental Toxicants Avoidance Study N/A
Completed NCT06217679 - Comparing the Effects of Different Types of Exercise on Glucose Handling N/A
Completed NCT00821665 - Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose N/A
Terminated NCT04171648 - Effect of Dry Roasted Peanuts and Boiled Peanuts on Glycemic Control N/A
Completed NCT05279183 - Assessment of Reward Responses to Erythritol Using Flavor Preference Learning N/A
Completed NCT05166200 - Glycemic Response in Adults With Type 2 Diabetes N/A
Not yet recruiting NCT05644717 - Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD Phase 4
Active, not recruiting NCT00283972 - LAP-BAND Observational Cohort Phase 4
Completed NCT00460499 - Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control Phase 1
Completed NCT00848315 - Diabetes Management in Low-Income Hispanic Patients Phase 2
Completed NCT03983499 - Latinos Understanding the Need for Adherence in Diabetes N/A
Active, not recruiting NCT05671965 - Effects of Oral Xylitol on Subsequent Energy Intake N/A